Gastrointestinal motor function in children treated with peritoneal dialysis
Rusthoven, E.; Trijbels-Smeulders, M.; Engels, F.A.; Groothoff, J.; Tolboom, J.J.; Monnens, L.A.; Schröder, C.H.
Peritoneal Dialysis International Journal of the International Society for Peritoneal Dialysis 21(1): 88-90
2001
ISSN/ISBN: 0896-8608 PMID: 11280505 Document Number: 536446
Document emailed within 1 workday
Related Documents
Makulska, I.; Zwolińska, D.; Kiliś-Pstrusińska, K.; Magier, K. 2001: Nutritional status of children treated with continuous ambulatory peritoneal dialysis and ambulatory peritoneal dialysis Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 10(58): 219-223Yelken, B.; Gorgulu, N.; Gursu, M.; Yazici, H.; Caliskan, Y.; Telci, A.; Ozturk, S.; Kazancioglu, R.; Ecder, T.; Bozfakioglu, S. 2014: Effects of spironolactone on residual renal function and peritoneal function in peritoneal dialysis patients Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis 30: 5-10
Schröder, C.H.; Bakkeren, J.A.; Weemaes, C.M.; Monnens, L.A. 1989: IgG2 deficiency in young children treated with continuous ambulatory peritoneal dialysis (CAPD) Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 9(4): 261-265
Qamar, I.U.; Levin, L.; Balfe, J.W.; Balfe, J.A.; Secker, D.; Zlotkin, S. 1994: Effects of 3-month amino acid dialysis compared to dextrose dialysis in children on continuous ambulatory peritoneal dialysis Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 14(1): 34-41
Baczyński, D.; Marciniak, M.; Olszowska, A.; Waniewski, J.; Weryński, A.; Wańkowicz, Z. 1998: Evaluation of peritoneal solute transport parameters in diabetics treated with continuous ambulatory peritoneal dialysis Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 5(29): 274-276
Opatrná, S.; Racek, J.; Stehlík, P.; Senft, V.; Sefrna, F.; Topolcan, O.; Opatrný, K. 2002: Effect of a dialysis solution with icodextrin on ultrafiltration and selected metabolic parameters in patients treated with peritoneal dialysis Casopis Lekaru Ceskych 141(9): 281-285
Jakić, M.; Stipanić, S.; Mihaljević, D.; Zibar, L.; Lovcić, V.; Klarić, D.; Jakić, M. 2005: The impact of glucose absorbed from dialysis solution on body weight gain in peritoneal dialysis treated patients Lijecnicki Vjesnik 127(5-6): 116-120
Krediet, R.T. 2001: Dialysate cancer antigen 125 concentration as marker of peritoneal membrane status in patients treated with chronic peritoneal dialysis Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 21(6): 560-567
Sułowicz, W. 1990: Activity of some lysosomal enzymes in peritoneal macrophages of patients with end-stage renal failure treated by intermittent peritoneal dialysis Folia Haematologica 117(5): 663-667
De Fijter, C.W.; Verbrugh, H.A.; Oe, P.L.; Peters, E.D.; van der Meulen, J.; Donker, A.J.; Verhoef, J.; Lameire, N. 1991: The effect of glycerol-containing peritoneal dialysis fluid on peritoneal macrophage function in vivo Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis 7: 154-157
Atkins, R.C.; Holdsworth, S.R.; Fitzgerald, M.G.; Hosking, C.S. 1978: The effect of maintenance dialysis on lymphocyte function. II. Peritoneal dialysis Clinical and Experimental Immunology 33(1): 102-106
Cueto-Manzano, A.M.; Rojas-Campos, E.; Martínez-Ramírez, H.éc.R.; Valera-González, I.; Medina, M.; Monteón, F.; Ruiz, N.; Becerra, M.; Palomeque, M.A.; Cortés-Sanabria, L. 2006: Can the inflammation markers of patients with high peritoneal permeability on continuous ambulatory peritoneal dialysis be reduced on nocturnal intermittent peritoneal dialysis? Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 26(3): 341-348
Duan, S.; Liu, F.; Xiao, P.; Xia, J.; Peng, Y.; Ye, Y.; Luo, J. 2001: The effect of lactate-buffered peritoneal dialysis fluid in human peritoneal mesothelial cells function Zhonghua Nei Ke Za Zhi 40(7): 463-466
Ueda, A.; Nagai, K.; Hirayama, A.; Saito, C.; Yamagata, K. 2017: Peritoneal Dialysis Preserves Residual Renal Function and Reduces Oxidative Stress During the Initial Period of Dialysis Therapy Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis 33(2017): 18-21
Twardowski, Z.J.; Moore, H.L.; Prowant, B.F.; Satalowich, R. 2009: Long-term follow-up of body size indices, residual renal function, and peritoneal transport characteristics in continuous ambulatory peritoneal dialysis Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis 25: 155-164
Riley, S.; Rutherford, P.A. 1998: Gastrointestinal side effects of ramipril in peritoneal dialysis patients Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 18(1): 83-84
Zharfbin, A. 2006: Dyslipidemia in patients being treated with peritoneal dialysis Vnitrni Lekarstvi 52(11): 1051-1057
Pietrzak, I.; Baczyk, K.; Ksiazek, P. 1995: Thiamine blood level and erythrocyte transketolase activity in continuous ambulatory peritoneal dialysis and intermittent peritoneal dialysis patients Annales Universitatis Mariae Curie-Sklodowska. Sectio D: Medicina 50: 197-203
Li, P.K.-T.; Chung, K.Y.; Chow, K.M. 2007: Continuous ambulatory peritoneal dialysis is better than automated peritoneal dialysis as first-line treatment in renal replacement therapy Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 27(Suppl 2): S153-S157
Kanjanabuch, T.; Puttipittayathorn, N.; Leelahavanichkul, A.; Lieusuwan, S.; Katavetin, P.; Mahatanan, N.; Sriudom, K.; Chirananthavat, T.; Thongbor, N.; Eiam-Ong, S. 2011: Exfoliated mesothelial cell and CA-125 in automated peritoneal dialysis (APD) and continuous ambulatory peritoneal dialysis (CAPD) patients Journal of the Medical Association of Thailand 94(Suppl 4): S119-S125